Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › LA › COVINGTON › ST. TAMMANY PARISH HOSPITAL SERVICE DISTRICT NO 1

ST. TAMMANY PARISH HOSPITAL SERVICE DISTRICT NO 1

NPI: 1598798597 · COVINGTON, LA 70433 · General Acute Care Hospital · NPI assigned 07/10/2006

$16.57M
Total Medicaid Paid
420,682
Total Claims
359,894
Beneficiaries
187
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialCOFFMAN, JOAN (CEO/PRESIDENT)
NPI Enumeration Date07/10/2006

Related Entities

Other providers sharing the same authorized official: COFFMAN, JOAN

ProviderCityStateTotal Paid
ST. TAMMANY PARISH HOSPITAL SERVICE DISTRICT NO 1 COVINGTON LA $1.56M
ST TAMMANY PARISH HOSPITAL SERVICE DISTRICT NO 1 COVINGTON LA $770K
ST. TAMMANY PARISH HOSPITAL SERVICE DISTRICT NO 1 MADISONVILLE LA $422K
ST. TAMMANY PARISH HOSPITAL SERVICE DISTRICT NO 1 COVINGTON LA $412K
ST TAMMANY PARISH HOSPITAL SERVICE DISTRICT NO 1 COVINGTON LA $142K
ST. TAMMANY PARISH HOSPITAL SERVICE DISTRICT NO 1 FOLSOM LA $123K
ST. TAMMANY PARISH HOSPITAL SERVICE DISTRICT NO 1 COVINGTON LA $24K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 40,423 $1.37M
2019 46,147 $1.68M
2020 30,640 $1.20M
2021 61,478 $2.66M
2022 90,775 $3.77M
2023 91,100 $3.47M
2024 60,119 $2.42M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 23,081 21,220 $3.45M
99284 Emergency department visit for the evaluation and management, high severity 29,540 26,897 $3.12M
99283 Emergency department visit for the evaluation and management, moderate severity 32,832 30,774 $2.40M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 30,193 25,930 $1.00M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 13,754 11,415 $673K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 5,294 4,769 $408K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 16,294 14,752 $362K
99232 Subsequent hospital care, per day, moderate complexity 12,923 4,426 $328K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 1,238 1,035 $312K
80053 Comprehensive metabolic panel 44,173 39,745 $307K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 5,283 4,737 $265K
99282 Emergency department visit for the evaluation and management, low to moderate severity 5,319 4,972 $238K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 5,836 5,273 $232K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 44,830 40,077 $228K
96375 Therapeutic injection; each additional sequential IV push 4,842 3,908 $198K
41899 Unlisted procedure, dentoalveolar structures 249 218 $159K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 1,336 1,207 $152K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1,358 1,177 $144K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 4,746 4,215 $134K
99223 Prolong inpt eval add15 m 1,986 1,639 $125K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 366 200 $96K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,672 1,511 $93K
99233 Prolong inpt eval add15 m 2,254 808 $90K
96361 Intravenous infusion, hydration; each additional hour 4,346 3,420 $84K
42820 Tonsillectomy and adenoidectomy; younger than age 12 200 169 $84K
81025 14,103 12,668 $80K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2,507 2,296 $80K
42830 128 123 $75K
25600 646 600 $70K
20610 1,842 1,414 $69K
73100 2,178 1,766 $67K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2,323 2,148 $66K
71045 Radiologic examination, chest; single view 3,591 3,253 $64K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 893 780 $62K
73610 1,931 1,677 $59K
70450 Computed tomography, head or brain; without contrast material 376 336 $57K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 950 810 $57K
74177 Computed tomography, abdomen and pelvis; with contrast material 138 125 $56K
84484 6,440 4,348 $46K
71046 Radiologic examination, chest; 2 views 2,548 2,354 $46K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1,581 459 $43K
73630 1,172 1,037 $42K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 300 285 $41K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 634 459 $40K
99239 Hospital discharge day management, more than 30 minutes 999 873 $38K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,857 1,476 $37K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 708 639 $37K
G0378 Hospital observation service, per hour 698 361 $35K
G0330 Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room 60 57 $33K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,212 897 $29K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 337 308 $27K
73564 518 471 $26K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 74 73 $26K
73110 647 570 $23K
J1885 Injection, ketorolac tromethamine, per 15 mg 5,458 4,786 $22K
81001 9,639 8,646 $21K
0240U 232 216 $21K
73030 682 594 $21K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 805 713 $17K
73140 431 376 $16K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation 610 546 $14K
36415 Collection of venous blood by venipuncture 7,252 6,002 $14K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 119 114 $12K
73080 373 336 $11K
83880 525 498 $11K
95810 Polysomnography; sleep staging with 4 or more additional parameters 26 24 $11K
J2405 Injection, ondansetron hydrochloride, per 1 mg 6,496 5,440 $11K
99281 Emergency department visit for the evaluation and management, self-limited or minor 292 286 $10K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 120 117 $10K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 170 132 $10K
99220 227 194 $9K
80050 General health panel 233 224 $9K
76819 Fetal biophysical profile; without non-stress testing 149 101 $8K
J7030 Infusion, normal saline solution , 1000 cc 203 186 $8K
59025 Fetal non-stress test 919 737 $8K
73521 189 171 $8K
73130 220 179 $8K
83735 1,754 1,551 $7K
73560 320 280 $7K
93017 104 99 $7K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 149 146 $7K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 1,490 1,298 $6K
81003 3,990 3,616 $6K
87634 90 84 $6K
93271 267 187 $6K
80061 Lipid panel 703 586 $5K
83690 1,092 996 $5K
27786 25 15 $5K
77073 116 103 $5K
73562 159 134 $4K
73590 157 119 $4K
94729 92 88 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 302 282 $4K
29085 124 100 $4K
99222 Initial hospital care, per day, moderate complexity 145 63 $4K
77067 Screening mammography, bilateral, including computer-aided detection 63 54 $3K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 12 12 $3K
93270 261 187 $3K
99215 Prolong outpt/office vis 61 55 $3K
76830 Ultrasound, transvaginal 27 27 $3K
86003 159 25 $3K
86803 183 176 $3K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 76 26 $3K
C1769 Guide wire 12 12 $3K
86703 225 216 $3K
84439 219 212 $2K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results 260 247 $2K
94799 85 71 $2K
J7120 Ringers lactate infusion, up to 1000 cc 3,572 2,513 $2K
94010 58 54 $2K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 27 26 $2K
94726 26 26 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 2,992 2,259 $2K
95806 31 30 $1K
96376 49 26 $1K
73090 51 38 $1K
83036 Hemoglobin; glycosylated (A1C) 169 156 $1K
87086 Culture, bacterial; quantitative colony count, urine 255 216 $1K
84481 115 111 $1K
72082 37 25 $1K
90670 39 39 $1K
94727 27 26 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,993 1,748 $1K
90686 349 295 $955.31
86850 388 318 $931.52
C1887 Catheter, guiding (may include infusion/perfusion capability) 12 12 $857.53
87070 86 82 $746.78
99238 Hospital discharge day management, 30 minutes or less 25 25 $733.60
26720 12 12 $728.41
72170 28 26 $710.25
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 12 12 $668.00
C1729 Catheter, drainage 13 13 $662.72
J2704 Injection, propofol, 10 mg 2,698 2,068 $642.59
99152 12 12 $616.74
99219 13 12 $577.60
0072A 21 13 $562.04
82785 30 25 $549.11
85027 142 128 $537.33
77063 Screening digital breast tomosynthesis, bilateral 63 54 $475.58
J2360 Injection, orphenadrine citrate, up to 60 mg 29 27 $473.22
73000 12 12 $446.28
80048 Basic metabolic panel (calcium, ionized) 153 107 $435.22
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 14 14 $427.57
86900 387 320 $423.63
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg 86 79 $423.38
86901 384 320 $419.33
J0696 Injection, ceftriaxone sodium, per 250 mg 45 42 $379.34
90472 Immunization administration, each additional vaccine (list separately) 783 534 $373.00
0002A 56 41 $370.80
82607 21 21 $351.75
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 17 16 $313.04
0225U 15 15 $312.59
82746 19 19 $310.46
J1170 Injection, hydromorphone, up to 4 mg 106 79 $284.16
82947 100 50 $282.96
72081 14 13 $280.50
82728 17 17 $257.55
J0131 Injection, acetaminophen, not otherwise specified,10 mg 49 37 $212.28
83550 18 18 $174.78
J3010 Injection, fentanyl citrate, 0.1 mg 593 439 $174.68
80179 13 12 $139.80
J0690 Injection, cefazolin sodium, 500 mg 1,280 1,106 $129.51
90647 24 24 $128.52
83540 18 18 $114.12
83605 22 12 $92.56
J2270 Injection, morphine sulfate, up to 10 mg 29 25 $69.80
A4217 Sterile water/saline, 500 ml 275 235 $67.88
82150 12 12 $64.80
J2250 Injection, midazolam hydrochloride, per 1 mg 66 54 $64.48
82550 26 12 $22.81
J2175 Injection, meperidine hydrochloride, per 100 mg 1,863 1,611 $17.01
99442 23 18 $11.70
J0171 Injection, adrenalin, epinephrine, 0.1 mg 1,955 1,614 $9.43
G0463 Hospital outpatient clinic visit for assessment and management of a patient 3,777 2,254 $0.00
1111F 90 70 $0.00
3008F 117 87 $0.00
91307 14 14 $0.00
0001A 16 15 $0.00
G0008 Administration of influenza virus vaccine 24 12 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 12 12 $0.00
J3490 Unclassified drugs 28 12 $0.00
1160F 367 325 $0.00
99490 Ccm add 20min 497 488 $0.00
1159F 370 328 $0.00
1124F 14 13 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 36 27 $0.00
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 23 22 $0.00